No black box warning on record for Pioglitazone Hcl And Metformin Hcl

As of the latest FDA labeling reviewed, Pioglitazone Hcl And Metformin Hcl (PIOGLITAZONE HCL AND METFORMIN HCL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Pioglitazone Hcl And Metformin Hcl medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure. Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk. Monitor patients for signs and symptoms. ( 5.1 ) • Edema: Dose-related edema may occur. ( 5.3 ) • Hypoglycemia: Consider a lower dose of insulin or insulin sec

No black box warning on record for Pioglitazone Hcl And Metformin Hcl

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure. Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk. Monitor patients for signs and symptoms. ( 5.1 ) • Edema: Dose-related edema may occur. ( 5.3 ) • Hypoglycemia: Consider a lower dose of insulin or insulin sec

Pioglitazone Hcl And Metformin Hcl Black Box Warning

No black box warning on record for Pioglitazone Hcl And Metformin Hcl

Other warnings & precautions

Pioglitazone Hcl And Metformin Hcl Black Box Warning

No black box warning on record for Pioglitazone Hcl And Metformin Hcl

Other warnings & precautions